Capsugel Advances the First Intrinsically Enteric Capsule Technology

 

Capsugel is a global leader in delivering high-quality, innovative dosage forms and solutions to its customers in the health care industry. The company’s Hard Capsule business unit offers customers the broadest portfolio of gelatin, vegetarian and other specialized capsule technologies. Capsugel’s Dosage Form Solutions business unit solves customers’ most pressing product development challenges, including bioavailability enhancement, modified release, abuse deterrence, biotherapeutic processing, and inhalation formulation. Capsugel Dosage Form Solutions accelerates and improves product development through an array of proprietary technologies including lipids and liquids, spray-dried dispersions, hot-melt extrusions, and through specialized manufacturing including FDA/MHRA-accredited finished dosage sites that can handle highly potent, controlled substance, hormonal and oncology compounds. Headquartered in Morristown, N.J., Capsugel serves more than 4,000 customers in more than 100 countries. For additional information, visit www.capsugel.com.

 

Expands lead-user program for breakthrough technology, providing customers with a new approach for enteric drug delivery.

Morristown, N.J., November 3, 2014 – Capsugel announced today the expansion of its lead-user customer-collaboration program for its intrinsically enteric capsule technology. This breakthrough drug-delivery technology integrates industry-approved enteric polymers in the capsule design, enabling Capsugel to offer the first fully enteric dosage form without the need to apply functional coatings.

Read more

Morristown, N.J., November 3, 2014, Capsugel Advances the First Intrinsically Enteric Capsule Technology, November 03, 2014, https://www.capsugel.com/news/capsugel-advances-the-first-intrinsically-enteric-capsule-technology

 

You might also like